drugset / Trial / NCT00004010

Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease

NCT00004010

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. Giving radiation therapy after chemotherapy may be an effective treatment for Hodgkin's disease. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating children who have previously untreated stage II, stage III, or stage IV Hodgkin's disease.

Timeline

Start
1999-10
Primary completion
2003-10
Completion
2008-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown Intravenous
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Dacarbazine Small molecule Intravenous
Subject Doxorubicin Other / unclassified Intravenous
Subject Etoposide Small molecule Intravenous
Subject Prednisone Other / unclassified Oral
Subject Vinblastine Small molecule Intravenous
Subject Vincristine Small molecule Intravenous
Subject filgrastim Protein / enzyme biologic Subcutaneous
Subject procarbazine Small molecule Oral

Indications